Las Vegas Medical Research

Vector Clinical Trials, formerly known as Las Vegas Medical Research, is a premier clinical research site network and site management organization (SMO) based in Las Vegas, Nevada. The company specializes in executing Phase I-IV clinical trials for global pharmaceutical and biotechnology sponsors, providing high-quality data and rapid patient enrollment. Vector's therapeutic expertise spans oncology, metabolic diseases, cardiovascular health, neurology, and gastroenterology. The organization is recognized for its community-focused approach, integrating clinical research into local physician practices to improve patient access to innovative treatments. In September 2025, Vector received a significant growth investment from QHP Capital to accelerate its expansion and enhance its operational capabilities. The company continues to play a vital role in the development of next-generation therapies for chronic and debilitating conditions.